PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12012013-0	2002	Induction of apoptosis in rat ventral prostate by finasteride is associated with alteration in MAP kinase pathways and Bcl-2 related family of proteins.	Finasteride	50-61	BCL2, apoptosis regulator	Rattus norvegicus	119-124	
12012013-10	2002	These findings suggest that modulation of MAP kinase and Akt expression, Bcl-xL, Bcl-xs, Bcl-2 and Bad proteins by finasteride may be, in part, responsible for the anti-proliferative and apoptotic effect of this drug seen clinically and in animal models.	Finasteride	115-126	BCL2, apoptosis regulator	Rattus norvegicus	89-94	
24250563-0	2012	BCL-2 and Bax Expression in Skin Flaps Treated with Finasteride or Azelaic Acid.	Finasteride	52-63	BCL2, apoptosis regulator	Rattus norvegicus	0-5	
24250563-3	2012	In present study, we evaluated the effect of azelaic acid 20% and finasteride on expression of BCL-2 and bax proteins after the skin flap surgery.	Finasteride	66-77	BCL2, apoptosis regulator	Rattus norvegicus	95-100	
24250563-5	2012	Both azelaic acid and finasteride increased the expression of BCL-2 protein (p < 0.05) and decrease the expression of bax protein (p < 0.05).	Finasteride	22-33	BCL2, apoptosis regulator	Rattus norvegicus	62-67